10 results
Membrane Actions of Antiarrhythmic Drugs

#Membrane #Channels #Actions #Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table
Drugs #Membrane ... #Channels #Actions ... #Antiarrhythmic ... #Pharmacology # ... Cardiology #Table
Clinical Pharmacologic Properties of Antiarrhythmic Drugs

#Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table #Effects
Clinical Pharmacologic ... Drugs #Antiarrhythmic ... #Drugs #Medications ... #Pharmacology # ... Cardiology #Table
Antiarrhythmics - Sodium Channel Blockers
Subclasses, Mechanisms, Indications, Side Effects
la - Quinidine, Procainamide
lb - Lidocaine, Mexiletine
Ic -
Antiarrhythmics ... - Sodium Channel ... Blockers #ClassI #Na #cardiology ... #pharmacology # ... table #comparison
Drugs affecting the cardiac action potential. The sharp rise in voltage ("0") corresponds to the influx
Drugs affecting ... to the sodium-channel ... voltage-sensitive calcium channels ... #Pathophys #Pharmacology ... #Cardiology #Antiarrhythmics
Class III Antiarrhythmics - Potassium Channel Blockers - Indications and Side Effects
Amiodarone
 • Suppression of VT
Class III Antiarrhythmics ... - Potassium Channel ... a-flutter (when other drugs ... #Blockers #pharmacology ... #cardiology
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics ... Pharmacology Summary ... Transient K+ efflux moving ... inotropy) ACCP Cardiology ... #Pharmacology #
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... management #algorithm #pharmacology ... #medications #table ... #decisionaid #cardiology ... hematology #warfarin #dosing
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Cardiovascular Drug-Drug ... tachycardia Calcium Channel ... arrhythmias Class I Antiarrhythmic ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... have been a few changes ... #Indications #Pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
then be excreted using ... algorithm #management #cardiology ... #treatment #table ... #criticalcare #icu ... #clinical #pharmacology